Literature DB >> 10514292

Heterodimeric tacrine-based acetylcholinesterase inhibitors: investigating ligand-peripheral site interactions.

P R Carlier1, E S Chow, Y Han, J Liu, J El Yazal, Y P Pang.   

Abstract

Dimeric acetylcholinesterase (AChE) inhibitors containing a single 9-amino-1,2,3,4-tetrahydroacridine (tacrine) unit were constructed in an effort to further delineate structural requirements for optimal binding to the AChE peripheral site. Basic amines of differing hydrophobicity were selected as peripheral site ligands, and in each case, improvements in inhibitory potency and selectivity were seen relative to tacrine itself. AChE IC(50) values of the optimum dimers decrease significantly as the peripheral site ligand was permuted in the series ammonia > dimethylamine > 4-aminopyridine > 4-aminoquinoline > tacrine. Calculated desolvation free energies of the optimum dimers match the trend in IC(50) values, suggesting the importance of ligand hydrophobicity for effective cation-pi interaction with the peripheral site.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10514292     DOI: 10.1021/jm990224w

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Pd-catalyzed amination as an alternative to nucleophilic aromatic substitution for the synthesis of N-alkyltacrines and analogues.

Authors:  Ming Ma; Jimit Mehta; Larry D Williams; Paul R Carlier
Journal:  Tetrahedron Lett       Date:  2011-02-23       Impact factor: 2.415

2.  Tacrine(10)-hupyridone, a dual-binding acetylcholinesterase inhibitor, potently attenuates scopolamine-induced impairments of cognition in mice.

Authors:  Huixin Chen; Siying Xiang; Ling Huang; Jiajia Lin; Shengquan Hu; Shing-Hung Mak; Chuang Wang; Qinwen Wang; Wei Cui; Yifan Han
Journal:  Metab Brain Dis       Date:  2018-03-21       Impact factor: 3.584

3.  Investigation of the binding mode of (-)-meptazinol and bis-meptazinol derivatives on acetylcholinesterase using a molecular docking method.

Authors:  Qiong Xie; Yun Tang; Wei Li; Xing-Hai Wang; Zhui-Bai Qiu
Journal:  J Mol Model       Date:  2006-01-11       Impact factor: 1.810

Review 4.  Hybrids: a new paradigm to treat Alzheimer's disease.

Authors:  Manjinder Singh; Maninder Kaur; Navriti Chadha; Om Silakari
Journal:  Mol Divers       Date:  2015-09-02       Impact factor: 2.943

5.  Design, synthesis and biological evaluation of tacrine-1,2,3-triazole derivatives as potent cholinesterase inhibitors.

Authors:  Gaochan Wu; Yun Gao; Dongwei Kang; Boshi Huang; Zhipeng Huo; Huiqing Liu; Vasanthanathan Poongavanam; Peng Zhan; Xinyong Liu
Journal:  Medchemcomm       Date:  2017-12-01       Impact factor: 3.597

Review 6.  Medicinal chemistry of acridine and its analogues.

Authors:  Parteek Prasher; Mousmee Sharma
Journal:  Medchemcomm       Date:  2018-08-14       Impact factor: 3.597

Review 7.  Acetylcholinesterase: a multifaceted target for structure-based drug design of anticholinesterase agents for the treatment of Alzheimer's disease.

Authors:  Harry M Greenblatt; Hay Dvir; Israel Silman; Joel L Sussman
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 2.866

8.  2,3-dihydro-1H-cyclopenta[b]quinoline derivatives as acetylcholinesterase inhibitors-synthesis, radiolabeling and biodistribution.

Authors:  Paweł Szymański; Alice Lázničková; Milan Lázniček; Marek Bajda; Barbara Malawska; Magdalena Markowicz; Elżbieta Mikiciuk-Olasik
Journal:  Int J Mol Sci       Date:  2012-08-13       Impact factor: 6.208

9.  2-{(E)-4-[4-(Trifluoro-meth-yl)phen-oxy]but-2-en-yloxy}phenyl N-methyl-carbamate.

Authors:  Hong-Ju Ma; Meng-Han Xu; Jian-Hua Zhang; Jian-Hong Li; Jun Ning
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-02-02

10.  Inhibition of acetylcholinesterase by two genistein derivatives: kinetic analysis, molecular docking and molecular dynamics simulation.

Authors:  Jiansong Fang; Ping Wu; Ranyao Yang; Li Gao; Chao Li; Dongmei Wang; Song Wu; Ai-Lin Liu; Guan-Hua Du
Journal:  Acta Pharm Sin B       Date:  2014-11-22       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.